Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
Behavioural Pharmacology October 13, 2015 Filip Tylš, Tomáš Páleníček, L. Kadeřábek et al. 86 citations
Psilocybin has recently attracted a great deal of attention as a clinical research and therapeutic tool. The aim of this paper is to bridge two major knowledge gaps regarding its behavioural pharmacology – sex differences and the underlying receptor mechanisms. We used psilocin (0.25, 1 and 4 mg/kg), an active metabolite of psilocybin, in two behavioural paradigms – the open-field test and...